Screener
Neuronetics STIM Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $41.57M+9.1% | $34.45M+7.8% | $41.78M+85.7% | $37.3M+101% | $38.11M+132% | ||
| $20.35M0.0% | $18.3M+12.7% | $20.07M+164% | $20.19M+346% | $20.35M+376% | ||
| $21.22M+19.5% | $16.15M+2.6% | $21.7M+45.7% | $17.11M+22.2% | $17.76M+45.8% | ||
| 51.1%+4.5pp | 46.9%-2.3pp | 52%-14.3pp | 45.9%-29.7pp | 46.6%-27.4pp | ||
| $1.34M-25.7% | $1.36M-15.6% | $1.67M-71.1% | $1.5M-37.7% | $1.8M-19.6% | ||
| $9.98M-15.9% | $10.74M-10.5% | $11.74M+19.7% | $11.85M-0.2% | $11.87M-3.5% | ||
| $11.4M-6.1% | $13.05M-0.7% | $13.34M+23.7% | $11.08M+49.0% | $12.15M+97.6% | ||
| $22.72M-12.0% | $25.15M-6.0% | $26.75M+1.4% | $24.43M+12.4% | $25.82M+24.8% | ||
| -$1.5M+81.4% | -$9M+18.3% | -$5.04M+56.0% | -$7.32M+5.3% | -$8.06M+5.3% | ||
| -3.6%+17.5pp | -26.1%+8.3pp | -12.1%+38.9pp | -19.6%+22.1pp | -21.1%+30.6pp | ||
| $2.13M+7.9% | $2.27M+17.9% | $2.32M+31.9% | $2.21M+27.9% | $1.97M-0.5% | ||
| $162K-13.8% | $1.02M+313% | $155K-71.7% | $126K-76.6% | $188K-71.2% | ||
| -$3.44M+66.0% | -$10.79M+14.9% | -$7.16M+43.5% | -$9.05M+32.2% | -$10.12M-2.9% | ||
| -8.3%+18.3pp | -31.3%+8.3pp | -17.1%+39.2pp | -24.3%+47.7pp | -26.6%+33.2pp | ||
| -$0.05+66.7% | -$0.16+23.8% | -$0.10+70.6% | -$0.13+70.5% | -$0.15+54.5% | ||
| -$772K+89.2% | -$8.25M+18.3% | -$4.28M+61.2% | -$6.44M+10.8% | -$7.16M+10.0% | ||
| -1.9%+16.9pp | -23.9%+7.7pp | -10.2%+38.8pp | -17.3%+21.7pp | -18.8%+29.6pp | ||
| -$1.5M+81.4% | -$9M+18.3% | -$5.04M+56.0% | -$7.32M+5.3% | -$8.06M+5.3% |
FAQ
- What is Neuronetics's revenue?
- Neuronetics (STIM) generated $155.1M in revenue over the trailing twelve months, up 39.6% year over year.
- Is Neuronetics profitable?
- Neuronetics is not currently profitable: it reported a net loss of $30.4M over the trailing twelve months, a -19.6% net margin.
- What are Neuronetics's profit margins?
- Gross margin is 49.1% and operating margin is -14.7%, with a -19.6% net margin.
- What is Neuronetics's earnings per share?
- Neuronetics's diluted EPS over the trailing twelve months is $-0.44.
- Where does Neuronetics's income statement data come from?
- Every line is extracted from Neuronetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
